Abstract
In idiopathic pulmonary fibrosis (IPF) patients the presence of missense polymorphisms (SNP) in members of the epidermal growth factor receptor (EGFR) family or their genetic association could influence the binding affinity of natural ligands, modifying the expression and the behavior of the correlated genes. EGFR family members are particularly involved in the epithelial injury and fibrotic process in IPF. Genetic variations in HER family of receptors may alter the possible therapeutic efficacy of EGFR inhibitors. This study aimed to analyze the relationships between IPF and specific EGF receptor family functional polymorphisms. We tested the presence of common EGFR, HER2 and HER3 non-synonymous SNPs in the peripheral blood of 20 Italian IPF patients and their association with the disease. Our data indicated that the HER2 variant allele frequency was significantly lower in patients than in controls, with an odds ratio of 0.31 (95% CI 0.080, 0.98). Our finding suggests that HER2 variant could be a protective factor against IPF onset.
Similar content being viewed by others
References
Sverzellati N, De Filippo M, Bartalena T, Piciucchi S, Zompatori M (2010) High-resolution computed tomography in the diagnosis and follow-up of idiopathic pulmonary fibrosis. Radiol Med 115:526–538. doi:10.1007/s11547-010-0512-5
du Bois RM (2010) Strategies for treating idiopathic pulmonary fibrosis. Nat Rev Drug Discov 9:129–140. doi:10.1038/nrd2958
Hardie WD, Davidson C, Ikegami M, Leikauf GD, Le Cras TD, Prestridge A, Whitsett JA, Korfhagen TR (2008) EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-alpha-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 294:L1217–L1225. doi:10.1152/ajplung.00020.2008
Hetzel M, Bachem M, Anders D, Trischler G, Faehling M (2005) Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 183:225–237. doi:10.1007/s00408-004-2534-z
Ishii Y, Fujimoto S, Fukuda T (2006) Gefitinib prevents bleomycin-induced lung fibrosis in mice. Am J Respir Crit Care Med 174:550–556. doi:10.1164/rccm.200509-1534OC
Rice AB, Moomaw CR, Morgan DL, Bonner JC (1999) Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats. Am J Pathol 155:213–221
Seifert RA, Hart CE, Phillips PE, Forstrom JW, Ross R, Murray MJ, Bowen-Pope DF (1989) Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J Biol Chem 264:8771–8778
Claesson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023–32026
Bauer-Mehren A, Furlong LI, Sanz F (2009) Pathway databases and tools for their exploitation: benefits, current limitations and challenges. Mol Syst Biol 5:290. doi:10.1038/msb.2009.47
Oda K, Matsuoka Y, Funahashi A, Kitano H (2005) A comprehensive pathway map of epidermal growth factor receptor signaling. Mol Syst Biol 1:1–17. doi:10.1038/msb4100014
Wells A (1999) EGF receptor. Int J Biochem Cell Biol 31:637–643
Hardie WD, Kerlakian CB, Bruno MD, Huelsman KM, Wert SE, Glasser SW, Whitsett JA, Korfhagen TR (1996) Reversal of lung lesions in transgenic transforming growth factor alpha mice by expression of mutant epidermal growth factor receptor. Am J Respir Cell Mol Biol 15:499–508
Madtes DK, Busby HK, Strandjord TP, Clark JG (1994) Expression of transforming growth factor-alpha and epidermal growth factor receptor is increased following bleomycin-induced lung injury in rats. Am J Respir Cell Mol Biol 11:540–551
Madtes DK, Rubenfeld G, Klima LD, Milberg JA, Steinberg KP, Martin TR, Raghu G, Hudson LD, Clark JG (1998) Elevated transforming growth factor-alpha levels in bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 158:424–430
Le Cras TD, Hardie WD, Fagan K, Whitsett JA, Korfhagen TR (2003) Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha. Am J Physiol Lung Cell Mol Physiol 285:L1046–L1054. doi:10.1152/ajplung.00045.2003
Carinci F, Pezzetti F, Scapoli L, Padula E, Baciliero U, Curioni C, Tognon M (1995) Nonsyndromic cleft lip and palate: evidence of linkage to a microsatellite marker on 6p23. Am J Hum Genet 56:337–339
Verma S, Slutsky AS (2007) Idiopathic pulmonary fibrosis–new insights. N Engl J Med 356:1370–1372. doi:10.1056/NEJMcibr070490
Selman M, Pardo A (2002) Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 3:3
Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, Pardo A, Westergren-Thorsson G, Selman M (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40:2129–2140. doi:10.1016/j.biocel.2008.02.012
Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180–13185. doi:10.1073/pnas.0605669103
Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA (2008) Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS One 3:e3220. doi:10.1371/journal.pone.0003220
Phan SH (2008) Biology of fibroblasts and myofibroblasts. Proc Am Thorac Soc 5:334–337. doi:10.1513/pats.200708-146DR
Selman M, Pardo A (2006) Role of epithelial cells in idiopathic pulmonary fibrosis: from innocent targets to serial killers. Proc Am Thorac Soc 3:364–372. doi:10.1513/pats.200601-003TK
Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z (2005) Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta 1: potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321–1332
Van Winkle LS, Isaac JM, Plopper CG (1997) Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol 151:443–459
Baughman RP, Lower EE, Miller MA, Bejarano PA, Heffelfinger SC (1999) Overexpression of transforming growth factor-alpha and epidermal growth factor-receptor in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 16:57–61
Faress JA, Nethery DE, Kern EF, Eisenberg R, Jacono FJ, Allen CL, Kern JA (2007) Bleomycin-induced pulmonary fibrosis is attenuated by a monoclonal antibody targeting HER2. J Appl Physiol 103:2077–2083. doi:10.1152/japplphysiol.00239.2007
Schaefer G, Shao L, Totpal K, Akita RW (2007) Erlotinib directly inhibits HER2 kinase activation and downstream signaling events in intact cells lacking epidermal growth factor receptor expression. Cancer Res 67:1228–1238. doi:10.1158/0008-5472.CAN-06-3493
Author information
Authors and Affiliations
Corresponding author
Additional information
Marcella Martinelli, Angela Maria Grazia Pacilli contributed equally to this work.
Rights and permissions
About this article
Cite this article
Martinelli, M., Pacilli, A.M.G., Rivetti, S. et al. A role for epidermal growth factor receptor in idiopathic pulmonary fibrosis onset. Mol Biol Rep 38, 4613–4617 (2011). https://doi.org/10.1007/s11033-010-0594-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-010-0594-0